Literature DB >> 7539020

The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope.

P Terness1, I Kohl, G Hübener, R Battistutta, L Moroder, M Welschof, C Dufter, M Finger, C Hain, M Jung.   

Abstract

Natural IgG anti-F(ab')2 Abs are part of the physiologic immune repertoire and have important immunoregulatory functions. Although previous work suggested that some of these Abs recognize epitopes located in the constant region of the F(ab')2 molecule, an exact epitope mapping has not been performed. We found that the anti-F(ab')2 Ab binds strongly to F(ab')2 but only weakly to Fab fragments. Fab fragments are lacking the core and lower hinge region. In our experiments, we show that the IgG anti-F(ab')2 Ab binds strongly to a synthetic double chain peptide (225-237/225'-237') comprising the core and lower hinge region of the human IgG1 molecule. In contrast, it binds only weakly to the same peptide in monomeric form (225-237) or to a short double chain hinge peptide (225-232/225'-232'). The double chain peptides comprise a cyclic region between the two cystine bridges and an exocyclic region. Previous nuclear magnetic resonance analyses showed that the cyclic portion of the short double chain hinge peptide adopts the same conformation as that found in the intact IgG1 molecule. The dichroic properties of the short and long double chain hinge peptides indicate that they have identical conformations in their cyclic regions, but have different conformations in their exocyclic regions. The conformational differences in the exocyclic regions explain the binding of the Ab to the long double chain hinge peptide and the lack of binding to the short one. The circular dichroism spectrum of the monomeric hinge peptide, which is not recognized by the Ab, is consistent with the absence of an ordered peptide structure. These findings lead us to conclude that the IgG anti-F(ab')2 Ab recognizes a conformational IgG1 hinge epitope.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539020

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Authors:  Randall J Brezski; Michelle Kinder; Katharine D Grugan; Keri L Soring; Jill Carton; Allison R Greenplate; Theodore Petley; Dorie Capaldi; Kerry Brosnan; Eva Emmell; Sharon Watson; Robert E Jordan
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

2.  Evading pre-existing anti-hinge antibody binding by hinge engineering.

Authors:  Hok Seon Kim; Ingrid Kim; Linda Zheng; Jean-Michel Vernes; Y Gloria Meng; Christoph Spiess
Journal:  MAbs       Date:  2016-08-09       Impact factor: 5.857

3.  Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1.

Authors:  M C Holland; J U Wurthner; P J Morley; M A Birchler; J Lambert; M Albayaty; A P Serone; R Wilson; Y Chen; R M Forrest; J C Cordy; D A Lipson; A I Bayliffe
Journal:  J Clin Immunol       Date:  2013-07-06       Impact factor: 8.317

4.  The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.

Authors:  M Welschof; P Terness; S M Kipriyanov; D Stanescu; F Breitling; H Dörsam; S Dübel; M Little; G Opelz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Inverse correlation between IgG-antihinge region and antierythrocyte autoantibody in chronic benign and malignant cold agglutination.

Authors:  P Terness; M Kirschfink; D Navolan; L Moroder; F Siedler; D Drugarin; F Schneider; C Dufter; I Kohl; M Welschof; G Opelz; D Roelcke
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

6.  Rheumatoid Factor and Anti-Modified Protein Antibody Reactivities Converge on IgG Epitopes.

Authors:  Aisha M Mergaert; Zihao Zheng; Michael F Denny; Maya F Amjadi; S Janna Bashar; Michael A Newton; Vivianne Malmström; Caroline Grönwall; Sara S McCoy; Miriam A Shelef
Journal:  Arthritis Rheumatol       Date:  2022-04-10       Impact factor: 15.483

7.  Molecular localization of human IgG anti-F(ab')2 reactivity with variable- and constant-region lambda light-chain epitopes.

Authors:  R C Williams; C C Malone; F Silvestris; A Solomon
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

8.  Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.

Authors:  Tao Huang; Mary Mathieu; Sophia Lee; Xinhua Wang; Yee Seir Kee; Jack J Bevers; Claudio Ciferri; Alberto Estavez; Manda Wong; Nancy Y Chiang; Gerald Nakamura; Randall J Brezski
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

9.  The hinge region fragment of immunoglobulin G improves immunogenicity of recombinant gonadotrophin-releasing hormone conjugated to the T-helper epitope in designing peptide vaccines.

Authors:  Jinshu Xu; Jie Wu; Xuejun Wang; Yin Zhang; Wenjia Li; Zheng Zhu; Dongya Zhu; Zhuoyi Hu; Rouel S Roque; Jingjing Liu
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

Review 10.  Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology.

Authors:  Yanchen Zhou; Hweixian L Penny; Mark A Kroenke; Bianca Bautista; Kelly Hainline; Lynette S Chea; Jane Parnes; Daniel T Mytych
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.